Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

CUSIP: 45258J102

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
202,731,676
Total 13F shares
39,828,501
Share change
+10,461,951
Total reported value
$1,401,617,459
Price per share
$35.19
Number of holders
116
Value change
+$384,378,297
Number of buys
91
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2020

As of 30 Sep 2020, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 116 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,828,501 shares. The largest 10 holders included RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, Cormorant Asset Management, LP, Polar Capital LLP, Point72 Asset Management, L.P., PERCEPTIVE ADVISORS LLC, PICTET ASSET MANAGEMENT LTD, ADAGE CAPITAL PARTNERS GP, L.L.C., and BVF INC/IL. This page lists 116 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.